GreenLight SPAC Presentation Deck

GreenLight peer benchmarking CY2021E EV / Revenue CY2022E EV / Revenue 24.1x GINKGO BIOWORKS (1) THE ORGANISH COMPANY 13.8x GINKGO BIOWORKS (1) Ag & Food Production 15.8x CODEXIS PROTEIN ENGINEERING EXPERTS 13.4x CODEXIS® PROTEIN ENGINEERING EXPERTS 11.9x amyris 11.2x Peer average: 15.6x 10.6x BENSON HILL Peer average: 14.4x 25.3x 8.4x NM Z zymergen amyris BENSON HILL z zymergen 61.6x 8.9x (2) moderna BIONTECH (³) mange thepics moderna Healthcare 30.9x 12.2x Peer average: 31.9x 17.8x UREVAC the RNA people 7.4x Peer average: 8.4x (4) Translate BIO BIONTECH 17.4x (4) Translate BIO Source: Company filings and FactSet as of 8/6/21. (3) BioNTech 2021 EV / sales reflects EV/LTM revenues. Investor Presentation | © 2021 GreenLight Biosciences. All rights reserved. GreenLight confidential. (4) Multiples reflect 8/3/21 announcement of Sanofi definitive agreement to purchase Translate Bio at $38/share 5.2x UREVAC the RNA people (1) Ginkgo 2021E EV/ sales reflects 2024E revenues, and 2022E EV / sales reflects 2025E revenues based on investor presentation. (2) Moderna 2021 EV/ sales reflects EV / LTM revenues. 43

View entire presentation